Management of myelodysplastic syndromes in the geriatric patient Ellen K. RitchieMark S. Lachs OriginalPaper 24 December 2008 Pages: 3 - 9
Myelodysplastic syndrome: An update on diagnosis and therapy Ahrin KoppelGary Schiller OriginalPaper 24 December 2008 Pages: 10 - 16
New and old prognostic factors in polycythemia vera Francesco Passamonti OriginalPaper 24 December 2008 Pages: 19 - 24
Do we know more about essential thrombocythemia because of JAK2V617F? Claire Harrison OriginalPaper 24 December 2008 Pages: 25 - 32
The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis Juergen ThieleHans Michael Kvasnicka OriginalPaper 24 December 2008 Pages: 33 - 40
Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons Thomas ElterBarbara F. EichhorstClemens-Martin Wendtner OriginalPaper 24 December 2008 Pages: 43 - 46
Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia Anders ÖsterborgClaes KarlssonJeanette Lundin OriginalPaper 24 December 2008 Pages: 47 - 53